Chen, Yu-Wei
Wang, Luke
Panian, Justine
Dhanji, Sohail
Derweesh, Ithaar
Rose, Brent
Bagrodia, Aditya
McKay, Rana R.
Article History
Accepted: 28 November 2023
First Online: 28 December 2023
Compliance with Ethical Standards
:
: Yu-Wei Chen has an immediate family member who has been employed by Amgen and owned stock. Luke Wang reported no conflict of interest. Justine Panian reported no conflict of interest. Sohail Dhanji reported no conflict of interest. Ithaar Deerweesh reported no conflict of interest. Brent Rose reported no conflict of interest. Aditya Bagrodia reported no conflict of interest. Rana R McKay has served on the consulting/advisory board for Aveo, AstraZeneca, Bayer, Bristol Myers Squib, Blue Earth Diagnostics, Calithera, Caris, Denderon, Exelixis, Janssen, Merck, Myovant, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Tempus and has received Institutional Research Funding from AstraZeneca, BMS, Exelixis, Artera, Oncternal, Bayer, Tempus.
: This article does not contain any studies with human or animal subjects performed by any of the authors.